Auxilium Pharmaceuticals Inc. (Nasdaq: AUXL) has purchased Actient Holdings LLC from private equity firm GTCR LLC for $585 million.

Actient, headquartered in Lake Forest, Ill., develops medicines that treat urological conditions. Since GTCR’s ownership in March 2009, Actient made five acquisitions, including Striant, a testosterone replacement medication and Timm Medical Technologies Inc., a company that provides products to treat erectile dysfunction.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.